A partnership between the Royal Marsden and Automata will see the UK’s first fully automated system for clinical cancer genomic testing.
Royal Marsden doubles genomic testing capacity through automation
A partnership between the Royal Marsden and Automata will see the UK’s first fully automated system for clinical cancer genomic testing.